{"filings":[{"id":96004,"accession_number":"0001213900-26-046405","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Spectral AI formalizes CEO Vincent Capone’s employment with $500k base, bonus, and RSU grant","event_type":"leadership","confidence":"high","bullets":["Annual base salary of $500,000; eligible for annual target bonus up to 100% of base, minimum $250,000.","RSU grant of 200,000 shares (50% vested April 1, 2026; 50% vest April 1, 2027).","Upon change of control, all RSUs vest immediately before closing.","Employment agreement dated April 17, 2026; Capone was previously appointed CEO on February 10, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96003,"accession_number":"0001213900-26-041479","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-04-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI appoints David McGuire as CFO, effective May 4, 2026","event_type":"leadership","confidence":"high","bullets":["David McGuire named CFO effective May 4, 2026; reports to CEO Vincent Capone.","Annual base salary $330,000; eligible for annual bonus up to 30% of base.","Receives option to purchase 150,000 common shares, vesting annually over three years.","McGuire previously CAO at Solo Brands and Deputy CFO/CAO at EZCORP; 14 years at EY.","Severance on without-cause termination: 3 months salary continuation and full vesting of options."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109498,"accession_number":"0001213900-26-034047","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-03-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Spectral AI Q4 net income $0.6M; FY 2025 revenue $19.7M; guides 2026 revenue ~$18.5M","event_type":"earnings","confidence":"high","bullets":["Q4 2025 net income $0.6M ($0.02 diluted EPS) vs net loss ($7.7M) in Q4 2024.","FY 2025 net loss narrowed to ($7.6M) from ($15.3M); R&D revenue $19.7M (down from $29.6M).","Cash at Dec 31, 2025 rose to $15.4M from $5.2M at Dec 31, 2024.","Received additional $31.7M BARDA funding; total BARDA contract up to $150M; De Novo 510(k) submitted for DeepView burn indication.","2026 revenue guidance ~$18.5M, primarily from BARDA contract; no material product sales expected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109497,"accession_number":"0001213900-26-032325","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-03-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI awarded $31.7M additional BARDA funding for DeepView System","event_type":"other_material","confidence":"high","bullets":["BARDA awards $31.7 million in non-dilutive funding to accelerate DeepView System development.","Company commits additional $9.7 million toward total development costs.","Funding supplements existing $54.9M BARDA contract (up to $150M) as FDA decision awaits.","Focus on burn wound imaging, including total body surface area mapping for mass casualty incidents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109496,"accession_number":"0001213900-26-014251","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI appoints Vincent S. Capone as CEO effective Feb 9, 2026","event_type":"leadership","confidence":"high","bullets":["Board dissolved Office of the Chairman; Capone previously served as CFO and General Counsel.","Capone has extensive background in law, accounting, finance, and operations; former KPMG, Reed Smith partner.","CEO transition comes as Spectral AI moves toward commercialization of DeepView burn wound assessment system.","FDA submission for DeepView System occurred in June 2025, a key milestone toward U.S. market entry.","Dr. J. Michael DiMaio remains Executive Chairman to ensure strategic continuity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109495,"accession_number":"0001213900-26-011432","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-02-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Spectral AI's Chief Commercial Officer Jeremiah Sparks steps down; 90-day consulting agreement","event_type":"leadership","confidence":"high","bullets":["Jeremiah Sparks resigned as CCO effective Feb 1, 2026 to pursue other opportunities, no disagreement with company.","Company has begun a national search for Sparks' replacement.","Sparks entered a 90-day consulting agreement at $4,000 per week for transition services.","Sparks will support ongoing projects during the transition period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109494,"accession_number":"0001213900-26-001781","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Colin Bristow resigns from Spectral AI board effective Jan. 5, 2026","event_type":"leadership","confidence":"high","bullets":["Colin Bristow resigned as director effective January 5, 2026.","Resignation not due to any disagreement with the company on operations, policies, or practices.","No replacement has been announced; board composition reduced accordingly."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126008,"accession_number":"0001213900-25-102145","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Spectral AI raises $7.6M in offering of common stock, warrants, pre-funded warrants","event_type":"other_material","confidence":"high","bullets":["Sold 3,065,000 shares at $1.90, plus 4,000,000 warrants ($2.51 exercise) and 935,000 pre-funded warrants ($0.0001).","Gross proceeds ~$7.6M; closed Oct 24, 2025; Northland Securities acted as placement agent (6% fee).","Proceeds for working capital and general corporate purposes; funds DeepView System development and commercial readiness in 2026.","Registration rights agreement requires filing Form S-3 within 10 days; stockholder approval needed for warrant shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142742,"accession_number":"0001213900-25-075636","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Spectral AI Q2 2025 revenue down 32% to $5.1M; net loss widens to $7.9M","event_type":"earnings","confidence":"high","bullets":["R&D revenue $5.1M in Q2 2025 vs. $7.5M in Q2 2024 (down 32.0%), reflecting completion of BARDA clinical trials.","Net loss of $(7.9)M in Q2 2025 vs. $(2.9)M in Q2 2024, primarily due to $(5.4)M fair value change in warrant liability.","Cash improved to $10.5M as of June 30, 2025, from $5.2M at Dec 31, 2024, aided by $8.5M debt draw and $2.7M equity.","Submitted De Novo application to FDA in June 2025 for the DeepView System, a key regulatory milestone.","Reiterated FY 2025 revenue guidance of approximately $21.5M, excluding commercial contributions from DeepView."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":11772000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160824,"accession_number":"0001213900-25-059623","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-06-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI submits De Novo request to FDA for DeepView burn assessment system","event_type":"regulatory","confidence":"high","bullets":["Spectral AI submitted a De Novo request to the FDA for its DeepView System on June 30, 2025.","DeepView System uses multispectral imaging and AI to assess burn wound healing potential within 7 days of injury.","Due to novel technology with no predicate device, the De Novo regulatory pathway is being pursued.","System trained on over 340 billion clinically validated data points to provide non-healing prediction.","DeepView received Breakthrough Device Designation from FDA in 2018."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160823,"accession_number":"0001213900-25-050760","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-06-03T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Spectral AI dismisses KPMG as auditor, engages Forvis Mazars for fiscal 2025","event_type":"other_material","confidence":"high","bullets":["Audit Committee unanimously voted to dismiss KPMG effective May 29, 2025.","No disagreements with KPMG during fiscal 2023 and 2024.","Previously reported material weaknesses in internal controls noted.","Engaged Forvis Mazars as independent registered public accounting firm for year ending Dec 31, 2025.","KPMG letter concurring with disclosures filed as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160822,"accession_number":"0001213900-25-049450","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI names Stanley Micek as permanent Chief Operating Officer","event_type":"leadership","confidence":"high","bullets":["Stanley Micek, previously interim COO since May 2024, appointed permanent COO effective May 30, 2025.","Base annual compensation set at $360,000 plus eligibility for discretionary bonus by Board.","Micek leads data science, software, hardware, imaging and systems teams for FDA submission of DeepView System.","Prior to interim COO, Micek was SVP Business Development & Strategy at MiMedx and held roles at Ohio State Univ.","Company focuses on AI-powered wound diagnostics for faster treatment decisions, with initial application in burn care."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160821,"accession_number":"0001213900-25-048888","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-05-29T23:59:59+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Spectral AI shareholders elect all six director nominees and ratify KPMG as auditor at annual meeting","event_type":"other_material","confidence":"high","bullets":["Annual meeting held May 28, 2025; 15.55M shares (60.8% of outstanding) represented.","All six director nominees elected: Bristow, Cotton, DiMaio, Mellish, Sadagopan, Snyder.","Colin Bristow elected as new director; all others re-elected from prior term.","Appointment of KPMG LLP as independent auditor for fiscal 2025 ratified with 15.38M for, 164K against.","No other proposals or material events disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}